UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma Journal article
Gu, Yongwei, Du, Yue, Jiang, Liangdi, Tang, Xiaomeng, Li, Aixue, Zhao, Yunan, Lang, Yitian, Liu, Xiaoyan, Liu, Jiyong. αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma[J]. Journal of Nanobiotechnology, 2022, 20(1).
Authors:  Gu, Yongwei;  Du, Yue;  Jiang, Liangdi;  Tang, Xiaomeng;  Li, Aixue; et al.
Favorite | TC[WOS]:28 TC[Scopus]:29  IF:10.6/11.4 | Submit date:2023/01/30
Crgd  Exosomes  Malignant Melanoma  Targeted Delivery  Triptolide  
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis Journal article
Liu, Xiaoyan, Lang, Yitian, Chai, Qingqing, Lin, Yan, Liao, Yahui, Zhu, Yizhun. Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Liu, Xiaoyan;  Lang, Yitian;  Chai, Qingqing;  Lin, Yan;  Liao, Yahui; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:4.4/5.0 | Submit date:2023/01/30
Atezolizumab  Cost-effectiveness  Metastatic Urothelial Cancer  Partitioned Survival Model  The Perspective Of The United States And China